Real-world effectiveness of 2nd-line treatments following 1L palbociclib + endocrine therapy: Preliminary results from the Non-Interventional Study PERFORM.

14. September 2026

M.P. Lux, M. Korell, G. Pfeiler, T. Gabrysiak, T. Fietz, M. Deryal, V. Petersen, T. Resch, B. Schöttker, T. Decker, L. Müller, J. Radosa, U. Rhein, M. Glasstetter, K. Gratzke, B. Sauer, A. Quartier, J. Dzieran, M. Cubas Cordova, R. Bartsch.

ESMO Open Volume 11, Supplement 4107485, 2026.

Abstract Poster